Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bristol-Myers Squibb Co (NYSE:BMY)

73.55
Delayed Data
As of 4:04pm ET
 +0.55 / +0.75%
Today’s Change
51.82
Today|||52-Week Range
75.12
+6.92%
Year-to-Date
Tesaro Stock Up on Successful Phase III Ovarian Cancer Trial
7:08pm / Zacks.com - Paid Partner Content
RedHill (RDHL) Stock Up on Positive Phase I Data on Yeliva
Jun 22 / Zacks.com - Paid Partner Content
McKesson Raises View Due to Accounting Changes, Stock Up
7:03pm / Zacks.com - Paid Partner Content
7 Profitable Medical Stocks Ranked as Buys Now
Jun 21 / Zacks.com - Paid Partner Content
Horizon (HZNP) Stock Up on Ravicti Label Expansion Filing
10:50am / Zacks.com - Paid Partner Content
3 Ways This $30 Billion Market Is Bristol's for the Taking
Jun 21 / MotleyFool.com - Paid Partner Content
AbbVie, J&J's Imbruvica Gets Breakthrough Therapy Status
10:18am / Zacks.com - Paid Partner Content
Gilead Presents Favorable Preliminary Bictegravir HIV Data
Jun 21 / Zacks.com - Paid Partner Content
Galena (GALE) Stock Falls on Discontinuation of NeuVax Study
8:50am / Zacks.com - Paid Partner Content
Vical (VICL) Reports Phase I/II Data on Genital Herpes Vaccine
Jun 21 / Zacks.com - Paid Partner Content
These Large Pharmaceutical Stocks Should be on your Radar
Jun 29 / Zacks.com - Paid Partner Content
Glaxo/Innoviva's Closed Triple Combination Tops Phase III
Jun 21 / Zacks.com - Paid Partner Content
McKesson's IT Business to Merge with Change Healthcare
Jun 29 / Zacks.com - Paid Partner Content
Epizyme Offers Early Data on Non-Hodgkin Lymphoma Drug
Jun 20 / Zacks.com - Paid Partner Content
Roche's Multiple Sclerosis Drug Under Review by FDA, EMA
Jun 29 / Zacks.com - Paid Partner Content
Auris (EARS) Begins Phase III Study for Sudden Deafness
Jun 20 / Zacks.com - Paid Partner Content
How Pfizer, Merck May Feel Long-term Pinch From Brexit
Jun 29 / TheStreet.com - Paid Partner Content
Emergent (EBS) BioThrax sBLA Accepted for FDA Review
Jun 20 / Zacks.com - Paid Partner Content
Esperion (ESPR) Offers Updates on LDL-Lowering Candidate
Jun 29 / Zacks.com - Paid Partner Content
3 Top Big Pharma Stocks to Buy Now
Jun 19 / MotleyFool.com - Paid Partner Content
Infinity Regains Duvelisib Rights, Announces Restructuring
Jun 29 / Zacks.com - Paid Partner Content
Kura (KURA) Begins Dosing in Phase II Study on Cancer Drug
Jun 17 / Zacks.com - Paid Partner Content
Endo's Stock Gains on Vasostrict's New Patent Approval
Jun 29 / Zacks.com - Paid Partner Content
Medivation's (MDVN) Pidilizumab Positive in Phase I/II Study
Jun 17 / Zacks.com - Paid Partner Content
Pfizer Investing $350M in China, Setting up Biotech Center
Jun 28 / Zacks.com - Paid Partner Content
Zacks.com featured highlights: B&G Foods, J. M. Smucker, Bristol-Myers Squibb, Pretiu...
Jun 17 / Zacks.com - Paid Partner Content
5 Medical Stocks to Buy with Great Dividend Yields
Jun 28 / Zacks.com - Paid Partner Content
Allergan Glaucoma Gel Stent Filing Accepted for FDA Review
Jun 17 / Zacks.com - Paid Partner Content
Cramer: Here's What's Behind the Horrible Politics of Brexit
Jun 28 / TheStreet.com - Paid Partner Content
Don't Make it Complicated, Own Drug Stocks
Jun 16 / Zacks.com - Paid Partner Content
Puma (PBYI) Submits Neratinib Marketing Application in EU
Jun 28 / Zacks.com - Paid Partner Content
Merck & Co., Inc. Wins This Round of the Immunotherapy Lung-Cancer Battle
Jun 16 / MotleyFool.com - Paid Partner Content
GW Pharmaceuticals Stock Up on Positive Epidiolex Data
Jun 28 / Zacks.com - Paid Partner Content
Stock Market News for June 16, 2016
Jun 16 / Zacks.com - Paid Partner Content
New Strong Buy Stocks for June 28th
Jun 28 / Zacks.com - Paid Partner Content
Emergent (EBS) BioThrax Gets Orphan Status in the U.S.
Jun 16 / Zacks.com - Paid Partner Content
Mylan Launches Generic Version of Glaxo's Avodart in U.S.
Jun 27 / Zacks.com - Paid Partner Content
Endo's (ENDP) Pain Drug Opana ER to Face FDA Panel in Fall
Jun 16 / Zacks.com - Paid Partner Content
Incyte Gains on Jakafi's Breakthrough Status for Acute GVHD
Jun 24 / Zacks.com - Paid Partner Content
Combat Volatility with These 5 Low Beta Stocks
Jun 16 / Zacks.com - Paid Partner Content
Why Investors Are Paying a Premium for These 3 Drugmakers
Jun 24 / MotleyFool.com - Paid Partner Content
Allied Minds: The search for fortune and glory
Jun 08 / FT.com - Paid Partner Content
Incyte Reports Epacadostat Combination Study Initiation
Jun 23 / Zacks.com - Paid Partner Content
Price of cancer drugs vastly higher in US, according to study
Jun 06 / FT.com - Paid Partner Content
GW Pharma (GWPH) to Develop Epidiolex for Infantile Spasms
Jun 22 / Zacks.com - Paid Partner Content
President raises patient and business hope for cancer treatment
Jun 02 / FT.com - Paid Partner Content